Thomas F.E. Barth

12.9k total citations · 2 hit papers
236 papers, 7.0k citations indexed

About

Thomas F.E. Barth is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas F.E. Barth has authored 236 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pathology and Forensic Medicine, 68 papers in Oncology and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas F.E. Barth's work include Lymphoma Diagnosis and Treatment (54 papers), Sarcoma Diagnosis and Treatment (31 papers) and Chronic Lymphocytic Leukemia Research (30 papers). Thomas F.E. Barth is often cited by papers focused on Lymphoma Diagnosis and Treatment (54 papers), Sarcoma Diagnosis and Treatment (31 papers) and Chronic Lymphocytic Leukemia Research (30 papers). Thomas F.E. Barth collaborates with scholars based in Germany, United States and Switzerland. Thomas F.E. Barth's co-authors include Peter Mӧller, Peter Möller, Reiner Siebert, Peter Lichter, Martin Bentz, Gunhild Mechtersheimer, Hartmut Döhner, Stephan Stilgenbauer, Ingo Melzner and Stefan Joos and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas F.E. Barth

226 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T-lymphocyte Infiltration in Visceral Adipose Tissue

2008 562 citations Thomas F.E. Barth et al. profile →
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

2013 372 citations Heike Horn, Marita Ziepert et al. profile →

Peers

Countries citing papers authored by Thomas F.E. Barth

Since Specialization

Citations

This map shows the geographic impact of Thomas F.E. Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F.E. Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F.E. Barth more than expected).

Fields of papers citing papers by Thomas F.E. Barth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F.E. Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F.E. Barth. The network helps show where Thomas F.E. Barth may publish in the future.

Co-authorship network of co-authors of Thomas F.E. Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F.E. Barth. A scholar is included among the top collaborators of Thomas F.E. Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F.E. Barth. Thomas F.E. Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA 2025 ·HemaSphere ·Katrin S. Kurz, (unknown), Markus Kreuz, Marita Ziepert, Annette M. Staiger, Thomas F.E. Barth, Peter Mӧller, Heinz‐Wolfram Bernd, Alfred C. Feller, Julia Richter, Wolfram Klapper, Harald Stein, Sylvia Hartmann, Martin‐Leo Hansmann, Lorenz Trümper, Markus Loeffler, Norbert Schmitz, Andreas Rosenwald, German Ott, Heike Horn, (unknown)	0
2	Host factor PLAC8 is required for pancreas infection by SARS-CoV-2 2025 ·Communications Medicine ·(unknown), Sandra Heller, (unknown), (unknown), Thomas F.E. Barth, Patricia Gallego, Israel Fernández‐Cadenas, (unknown), Catalina Crespı́, (unknown), Eugenia Cisneros‐Barroso, Alejandro P. Ugalde, Gabriel Bretones, Charlotte Steenblock, Alexander Kleger, Marta L. DeDiego, Carles Barceló	0
3	Mucins Shed from the Laminated Layer in Cystic Echinococcosis Are Captured by Kupffer Cells via the Lectin Receptor Clec4F 2023 ·Infection and Immunity ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ana Paula Mulet, Tsui-Ling Hsu, Shie-Liang Hsieh, Gustavo Mourglia‐Ettlin, (unknown), Martina Crispo, Thomas F.E. Barth, Cecilia Casaravilla, Stephen J. Jenkins, Álvaro Díaz	5
4	Novel approach to assessing the primary stability of dental implants under functional cyclic loading in vitro: a biomechanical pilot study using synthetic bone 2023 ·Journal of Periodontal & Implant Science ·(unknown), Stefan Schleifenbaum, (unknown), Thomas F.E. Barth, (unknown), Sabine Löffler	0
5	DNA methylation‐associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesis 2023 ·The Journal of Pathology ·Jana Krüger, (unknown), Markus Breunig, (unknown), (unknown), Jessica Merkle, Medhanie Mulaw, (unknown), (unknown), C. Morgenstern, Ninel Azoitei, Thomas Seufferlein, Thomas F.E. Barth, Reiner Siebert, Meike Hohwieler, Alexander Kleger	3
6	An unusual presentation of invasive Fusarium aortitis in a patient who is immunocompromised: A case report 2023 ·International Journal of Infectious Diseases ·(unknown), (unknown), (unknown), Beate Grüner, C Skrabal, Thomas F.E. Barth, (unknown), (unknown), Lynn Peters, Grit Walther, (unknown)	1
7	Establishing and evaluation of a polymerase chain reaction for the detection of Echinococcus multilocularis in human tissue 2021 ·PLoS neglected tropical diseases ·Johannes Grimm, (unknown), A. Beck, (unknown), (unknown), Dennis Tappe, Beate Grüner, Thomas F.E. Barth, Klaus Brehm	13
8	A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial 2021 ·BMC Cancer ·(unknown), Lisa Kaiser, (unknown), (unknown), Andreas Viardot, Peter Mӧller, Thomas F.E. Barth, Rainer Muche, Jens Dreyhaupt, Markus Raderer, Barbara Kiesewetter, Christian Buske	5
9	Case Report and Review of the Literature of a Rare Entity of a Uterine Fibroid: A Genital Rhabdomyoma 2019 ·International Journal of Gynecological Pathology ·(unknown), (unknown), Thomas F.E. Barth, (unknown), Peter Widschwendter, Wolfgang Janni, Katharina Hancke	1
10	Intra-articular extra-axial chordoma of the wrist: a case report with review of the current literature 2019 ·Skeletal Radiology ·Jan Neumann, Alexandra S. Gersing, Thomas F.E. Barth, Melanie Boxberg, Klaus Woertler	9
11	LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis 2018 ·Clinical Cancer Research ·(unknown), Matthias Fischer, Thomas F.E. Barth, Wolfgang Mueller‐Klieser, Barbara Hero, Judith Gecht, Daniel R. Carter, Katleen De Preter, Benjamin Mayer, (unknown), Frank Speleman, Glenn M. Marshall, Klaus‐Michael Debatin, Christian Beltinger	54
12	Autochthonous human alveolar echinococcosis in a Hungarian patient 2016 ·Infection ·(unknown), (unknown), (unknown), Judit Csomor, (unknown), Peter Kern, Giovanni Rezza, Thomas F.E. Barth, Adriano Casulli	10
13	Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway 2015 ·Cancer Research ·Adrian von Witzleben, (unknown), Ralf Marienfeld, Holger Barth, André Lechel, Kevin Mellert, (unknown), Marko Kornmann, Regine Mayer‐Steinacker, Alexandra von Baer, Markus Schultheiß, Adrienne M. Flanagan, Peter Mӧller, Silke Brüderlein, Thomas F.E. Barth	65
14	In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival 2015 ·European Spine Journal ·Adrian von Witzleben, (unknown), Jochen K. Lennerz, Stephanie E. Weissinger, Marko Kornmann, Regine Mayer‐Steinacker, Alexandra von Baer, Markus Schultheiß, Peter Möller, Thomas F.E. Barth	20
15	Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells 2013 ·Cancer Research ·Stefanie Lindner, Karen Dahlke, Kai Sontheimer, Magdalena Hagn, Christof Kaltenmeier, Thomas F.E. Barth, Thamara Beyer, Frank Reister, Dorit Fabricius, Ramin Lotfi, Oleg Lunov, G. Ulrich Nienhaus, Thomas Simmet, R. Kreienberg, Peter Möller, Hubert Schrezenmeier, Bernd Jahrsdörfer	273
16	High‐resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B‐cell lymphoma and its large cell variant 2012 ·International Journal of Cancer ·(unknown), Karlheinz Holzmann, Torsten Mattfeldt, (unknown), (unknown), Michael Held, Peter Mӧller, Thomas F.E. Barth	18
17	Human B cells differentiate into granzyme B‐secreting cytotoxic B lymphocytes upon incomplete T‐cell help 2011 ·Immunology and Cell Biology ·Magdalena Hagn, Kai Sontheimer, Karen Dahlke, (unknown), Christof Kaltenmeier, Thamara Beyer, Stefanie Hofmann, Oleg Lunov, Thomas F.E. Barth, Dorit Fabricius, Kyrylo Tron, G. Ulrich Nienhaus, Thomas Simmet, Hubert Schrezenmeier, Bernd Jahrsdörfer	82
18	Target Sequence Accessibility Limits Activation-Induced Cytidine Deaminase Activity in Primary Mediastinal B-Cell Lymphoma 2007 ·Cancer Research ·Sergey Popov, Gerhard Moldenhauer, (unknown), Silke Brüderlein, Thomas F.E. Barth, Karola Dorsch, Olga Ritz, Peter Möller, Frank Leithäuser	6
19	Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells 1997 ·International Journal of Cancer ·Thomas F.E. Barth, Silke Brüderlein, N. Rinaldi, Gunhild Mechtersheimer, Peter Möller	2
20	Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells 1997 ·International Journal of Cancer ·Thomas F.E. Barth, Silke Brüderlein, N. Rinaldi, Gunhild Mechtersheimer, Peter Möller	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact